17 Despite their identification several years ago, molecular identity and developmental relation 18 between human ILC1 and NK cells, comprising group 1 ILCs, is still elusive. To unravel their 19
Introduction
So far, definitions of ILC1 are predominantly based on work in solid organs and tissues such 93 as gut and lymph nodes (Bernink et al., 2013; Bjorklund et al., 2016) . In contrast, for circulating 94 ILC1, information on origin, function, and developmental potential is still at its infancy. Given 95 that the accessibility of ILCs in humans is mostly restricted to blood, an increased 96 understanding of the biology of blood-borne ILC and their respective progenitors appears to be 97 of pivotal importance for guiding and implementing future ILC-based cellular therapies. Of 98 note, in PB it was recently shown that lin -CD117 + cells, phenotypically resembling ILC3, were 99 observed to be functionally immature but instead could be differentiated into all ILC subsets 100
including NK cells (Lim et al., 2017) . 101 102
In the present study, a thorough characterization of circulating type 1 ILC was performed in 103 human umbilical cord blood (CB). CB represents a highly versatile and ethically non-104 problematic source of neonatal blood with low pathogenic burden that was recently shown to 105 be enriched for ILCs compared to PB (Vely et al., 2016) . Our work demonstrates that CB-106 derived ILC1-like cells are distinct from NK cells on the transcriptional, epigenetic, and 107 functional level but rather constitute NK cell progenitors (NKP) with a unique propensity to 108 generate clonally diversified NK cell repertoires in vitro. A similar ILC1-like subset, albeit at 109 lower frequency, was also found in peripheral blood. 110 111
Results 112 113
Distinct transcriptional identities of neonatal circulating ILC1-like cells and NK cells 114
The transcriptional basis underlying the phenotypic and functional differences between NK 115 cells and ILC1, together comprising the group 1 ILC family, is poorly defined in the circulation 116 and direct comparisons between ILC1 and NK cells by bulk RNA sequencing are so far not 117 available. A central purpose of the present study was to characterize group 1 ILC in CB, which 118 provides a rich source for ILCs comprising all three ILC subsets as well as both major NK cell 119 subsets, the regulatory CD56 bright and the cytotoxic CD56 dim NK cells . 120
To this end, ILC1-like cells, defined as lin -CD94 -CD127 + CRTH2 -CD117cells, CD56 bright NK 121 cells, and CD56 dim NK cells were flow cytometrically sorted from freshly collected CB and 122 subjected to RNAseq analysis ( Fig. S1 ). All three group 1 ILC subsets could be clearly 123 separated from each other on the basis of their transcriptional patterns in the heatmap and 124 principal component analysis ( Fig. 1a, b ). PC1, which accounts for 56% variance in the data, 125
differentiates between the three cell subsets with ILC1-like cells clearly separated from 126 CD56 dim NK cells and CD56 bright NK cells. Within PC2 accounting for 16% of variance, all 127 three subsets could be further separated from each other with ILC1-like cells being more similar 128 to CD56 dim NK cells than CD56 bright NK cells. 129 130
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[NK_bright] CD161 APC-A700-A / CD117 PB450-A CD161 APC-A700-A 10 1 10 2 10 3 10 4 10 5 10 6 10 7 CD117 PB450-A Gate Number %Total %Gated All 97 0,01 100,00 X--3 0,00 3,09 X-+ 2 0,00 2,06 X+-88 0,01 90,72 X++ 4 0,00 4,12
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When analyzing the most differentially expressed genes ( Fig. 1a , c-d), ILC1-like cells were 156 distinguished from NK cells by the lack of expression of typical NK cell markers such as CD56 157 (NCAM1), NKp46 (NCR1), NKp80 (KLRF1), NKG2A (KLRC1), and CD94 (KLRD1), low 158 expression of receptor subunits for key innate cytokines IL-2 (IL2RB), IL-12 (IL12RB2), and 159 IL-18 (IL18RAP), as well as lack of cytotoxic effector molecules perforin (PRF1), granulysin 160 (GNLY), and all five members of the granzyme family. Whereas ILC1-like cells were 161 apparently lacking basic NK cell characteristics, several of the most highly expressed genes 162 within ILC1-like cells turned out to encode proteins associated with the T cell lineage including 163
T cell surface markers CD5, CD6, and CD28 ( Fig.1a , c-d). Furthermore, specific components 164 of the T-cell receptor (TCR) unit such as TCRB constant chain (TRBC1) and CD3d (CD3D) 165
were more strongly transcribed in ILC1-like cells, albeit moderate transcription was also 166 present in NK cells, particularly the more mature CD56 dim subset ( Fig. 1a ). Nevertheless, ILC1-167 like cells lacked surface expression of CD3, TCR , and TCR ( Fig. 1d ). On the basis of 168 CD161 that has been previously described to be expressed on tonsillar ILC1(Bernink et al., 169 2013) and the T cell marker CD5, ILC1-like cells could be further subdivided into two main 170 subsets, a major CD5 + CD161subset co-expressing other T cell lineage markers such as CD6 171 and CD28 and a minor CD5 -CD161 + population lacking these T cell markers ( Fig. 1e and S2 ). 172 173 We next analyzed the expression of lineage-determining transcription factors. Inhibitor of DNA 174 binding 3 (ID3), a helix-loop-helix (HLH) protein that is generally expressed in the T cell but 175 not NK cell lineage was found to be highly transcribed in ILC1-like cells but not NK cells, 176 again pointing towards a closer relationship of ILC1-like cells to T cells ( Fig. 1a, c) . 177
Furthermore, Eomesodermin (Eomes) encoding a key transcription factor for NK cell 178 development, was highly expressed in NK cells, but also found to be moderately expressed in 179 ILC1-like cells by RNAseq analysis and also by intranuclear staining (Fig. 1d, Fig. S3 ). Finally, 180
TBET (TBX21), originally reported to be a defining feature of both, ILC1 and NK cells, was 181 strongly expressed on EOMES + NK cells, whereas it was almost absent on ILC1-like cells ( Fig.  182 1d, Figure S3 ). Together, we show that neonatal circulating ILC1-like cells have a unique  183  transcriptional identity distinct from NK cells and on the other hand exhibiting phenotypic  184  similarities with T cells including expression of lineage markers, TCR components, and  185  transcription factors.  186  187 Expression of chemotactic receptors suggests differential migratory behavior of ILC1-188 like subsets and NK cells 189
Among the most significant changes identified by transcriptional analysis between ILC1-like 190 and NK cells were the chemokine receptors CCR7, which plays a key role in promoting 191 migration to secondary lymphoid organs, as well as CCR4 and CCR9 which are involved in 192 migration to skin and small intestine, respectively(Oo and Adams, 2010) ( Fig. 1c and 2a ). All 193 three receptors were prominently expressed in ILC1-like cells but lacking or weakly expressed 194 in CD56 dim and CD56 bright NK cells, respectively. The chemokine receptor pattern of the ILC1-195 like subset was reminiscent of peripheral T cells and suggests fundamentally different 196 migratory properties of ILC1-like cells under steady-state conditions compared to circulating 197 NK cells. In contrast, NK cells but not ILC1-like cells exhibited high levels of the Sphingosine-198 1 phosphate (S1P) receptor S1PR5, which is a potent chemotactic regulator of tissue residency 199 ( Fig. 2a ) suggesting that circulating neonatal NK cells, in particular CD56 dim cells, are more 200 bound to stay within the circulation compared to ILC1-like cells. 
221
In accordance with the RNAseq data ( Fig. 1c ), CCR7 was highly expressed on the cell surface 222 of ILC1-like cells but barely detectable on NK cells (Fig. 2b ). In case of CCR9, high surface 223
expression was found on small subsets of CCR7 + and CCR7 -ILC1-like cells (12.97% vs 8.74%) 224
but not NK cells. We further observed a distinct CCR4 + ILC1-like subset (15.72%), but no 225 CCR4 expression on NK cells ( Fig. 2b ). Further analysis of the distribution of chemokine 226 receptors on the subsets defined by CD5 and CD161 expression shown above ( Fig. 1e ) by t-227 distributed stochastic neighbor embedding (t-SNE) analysis revealed that CCR4, CCR7 and 228 CCR9 expression was restricted to CD5 + ILC1-like cells, (either CD5 + CD161or 229 CD5 + CD161 + ), whereas the small CD5 -CD161 + subset did not express any of the three 230 chemokine receptors ( Fig. 2c-d ). The data thus demonstrate that the majority of ILC1-like cells 231 (CD5 + CD161 +/-) express chemokine receptors enabling migration into various tissues, whereas 232 a small subset (CD5 -CD161 + ), similar to NK cells, lack this property. 233 234 IFN production is restricted to CD161 + ILC1-like cells 235
A key effector function of ILC1 cells is the rapid production of IFN in response to 236 inflammatory cytokines. Unexpectedly, only very few ILC1-like cells exhibited intracellular 237 IFN production (mean: 1,25%), whereas the large majority of CD56 bright NK cells readily 238 produced IFN as expected (mean: 80,3%), ( Fig. 2e ). Similarly, upon polyclonal stimulation 239 with PMA/Ionomycin, ILC1-like cells were again largely unable to produce IFN ( Fig. 2f ). 240
Even over an extended period of five days, ILC1-like cells produced very low amounts of IFN , 241
again in contrast to NK cells ( Fig. 2g ). Importantly, differential effector functions were noted 242 when comparing the major CD5 + CD161and the minor CD5 -CD161 + subsets. The CD161 + 243 subset contained a small fraction of cells able to produce IFN after short-term cytokine 244 stimulation, whereas IFN -producing cells were almost undetectable in the major CD161 -245 subset (mean: 8.2% vs. 0.9%), (Fig. 2h ). Together, the data suggest that the majority of ILC1-246 like cells (CD5 + CD161 -) are functionally immature but that a minor subset of CD5 -CD161 + 247 cells exerts IFN -mediated effector functions. 248 249
Decline of circulating ILC1-like cells with gestational age 250
The pattern of chemokine and S1P receptor expression suggested fundamentally different 251 migratory properties of neonatal ILC1-like cells compared to circulating NK cells under steady-252 state conditions. In particular, CCR7 expression was most prominent in ILC1-like cells 253
suggesting their efficient migration to secondary lymph nodes. In order to better understand 254 the dynamics of ILC subsets in the circulation around birth, ILC frequencies were analyzed in 255 CB according to gestational age. As shown in Fig. 3 , CD56 bright and CD56 dim NK cell frequency 256
as well as total cell count seemed largely unaffected by changes in gestational age. In contrast, 257 a significant decrease of ILC1-like cells in terms of frequency (r=0.9286, p-value= ** 0.0067) 258 and total cell number (r=0.8929, p-value= *0.0123) was found with increasing gestational age 259 of the CB . The decline was specific for ILC1-like cells and not observed for ILC2 and ILC3  260 subsets, which showed no significant changes in either direction by gestational age. Analysis 261 of ILC frequencies in adults revealed no further decline of ILC1-like cells in young and middle-262 aged (18-55 years) or elderly (63-86 years) adults. In contrast, a strong decline was observed 263 for ILC2 and ILC3 subsets from neonatal to adults with an additional significant decrease from 264 middle-aged to elderly adults ( Fig. 3) . Thus, transcriptomic, phenotypic, and age-related 265 analysis suggest a unique as well as highly dynamic role of ILC1-like cells in the circulation 266 before and around the time of birth. 267 268 269 Neonatal ILC1-like cells contain a novel NK cell progenitor 282
Figure 3 | Frequency and cell count of ILC1-like cells from CB inversely correlates with
Based on the observation that the large majority of neonatal ILC1-like cells are functionally 283 immature, we next explored the possibility that they constitute a novel type of lymphoid 284 progenitor. To this end, the two main ILC1-like subsets expressing CD5 + (CD161 -/+ ) or lacking 285 4a). The ILC1-like subsets were compared to CD56 bright NK cells constituting a well-described 289 immediate progenitor of mature NK cells and to ILC2 cells (lin -CD94 -CD127 + CRTH2 + ), 290
representing an innate lymphocyte subset supposedly lacking NK cell differentiation potential. 291
When ILC1-like cells were subjected to T cell differentiation conditions (Wang et al., 2006) , 292 very few cells survived the first 8 days of differentiation ( Fig. S4 ) and no CD3 + T cells could 293
be detected suggesting that under these conditions ILC1-like cells do not efficiently 294 differentiate into the T cell direction. In contrast, when subjected to NK cell differentiation 295 conditions, CD5 + as well as CD5 -ILC1-like cells up-regulated CD94 and NKG2A expression 296 de novo. Remarkably, ILC1-like cells more efficiently differentiated into mature KIR + NK cells 297 than CD56 bright NK cells, which largely maintained their initial NKG2A expression ( Fig. 4b ). 298 ILC2 remained negative for CD94 and NKG2A receptors. 
318
Based on the rapid upregulation of NK cell receptors on ILC1-like cells in culture we were 319
wondering if the respective genes were already epigenetically poised for transcription. To this 320 end, we analyzed sorted neonatal ILC1-like cells as well as NK cells by ATACseq, constituting 321 a sensitive global method to assess chromatin accessibility, which serves as correlate for 322 epigenetic remodeling of the locus. Whereas in CD56 bright NK cells, the CD94, NKG2A, and 323 KIR2DL3 genes exhibited highly accessible chromatin regions around the transcriptional start 324 points as expected, in ILC1-like cells only moderate (CD94) or no signs of chromatin 325 remodeling (NKG2A, KIR2DL3) were found ( Fig. 4c ), excluding epigenetic conditioning 326 towards expression of these NK cell receptors. In contrast, T cell specific markers such as CD5 327
and CD161 exhibited open chromatin structures in the 5`-regulatory regions in ILC1-like cells 328
whereas they were inaccessible in NK cells ( Fig. S2c ). 329 330 NK cells derived from neonatal ILC1-like cells are functionally mature 331 We next assessed the functional properties of the putative NK cell population generated from 332 neonatal ILC1-like cells in vitro. Analysis of CD107a mobilization, representing a correlate for 333 the degranulation of cytotoxic granules, revealed a high frequency (mean: 61,1%) of CD107a + 334 ILC1-like-derived NK cells upon incubation with the HLA class I-deficient target cell line 335 K562, comparable to the results with CD56 bright NK cells ( Fig. 5a ). Assessment of direct 336 cytotoxicity similarly revealed comparable effector functions of NK cells derived from ILC1-337 like cells or CD56 bright NK cells ( Fig. 5b ). Furthermore, NK cells derived from ILC1-like cells 338
showed upregulation of CD16, constituting an important Fc receptor type for mediating 339 antibody-dependent cellular cytotoxicity (ADCC) ( Fig. 5c ). When incubating the in vitro 340 generated NK cells with the CD20-specific antibody Rituximab and the CD20 + B cell line Raji, 341 specific ADCC function was observed (mean: 37,4%) without spontaneous CD107a release in 342 the control condition ( Fig. 5d ). Together, NK cells from ILC1-like cells exhibit key NK cell 343 effector functions including mobilization of cytotoxic granules, killing of HLA-deficient target 344 cells, and CD16-mediated ADCC. 345 346 
361

ILC1-like cells acquire KIR receptors in a NOTCH-dependent manner 362
Others and we had previously shown that the presence of Notch ligands such as delta ligand 1 363 (DLL1) in the hematopoietic niche plays a key role in instructing NK cell progenitors for later 364 KIR expression (Miller et al., 1999; Zhao et al., 2018) . In order to evaluate a possible role for 365 NOTCH ligands in our system, experiments were repeated in a purely cytokine-based 366 environment as well as on OP9 stromal cells lacking DLL1 expression and then compared to 367 the original conditions using the DLL1-transfected OP9-DL1. The experiments using sorted 368 CB-derived ILC1-like cells and CD56 bright NK cells revealed that stroma cells are generally 369
promoting NK cell differentiation of ILC1-like cells (Fig. 6 ), as previously seen for established 370 stage 2 (CD34 + CD117 + ) NK cell progenitors. CD94 + NKG2A + NK cells were generated with 371 highest frequency on OP9, followed by OP9-DL1 cultures and with only low frequency in 372 stroma free conditions ( Fig. 6a-b the presence of DLL1-transfected stroma cells had a significant influence on KIR expression: 376 OP9-DL1 cells efficiently supported the generation of KIR2DL2/3 + NK cells whereas on OP9 377 stroma cells lacking DLL1 only few KIR2DL2/3 + NK cells were generated. This effect was 378 similarly seen for CD56 bright NK cells, albeit on a lower quantitative level ( Fig. 6a-b ). Of note, 379 despite functional heterogeneity within the ILC1-like subsets, CD5 + (CD161 -) and CD5 -380 (CD161 + ) subsets were similarly capable of differentiating into mature NK cells. In order to more thoroughly assess the NK cell differentiation potential of ILC1-like cells we 404
surveyed the complexity of the in vitro generated NK cell repertoires by analyzing expression 405 of NKG2A together with KIR2DL1, KIR2DL2/2DL3, and KIR3DL1, representing the major 406 inhibitory receptors for the four HLA class I-encoded epitopes E, C2, C1, and Bw4, 407
respectively. Furthermore, KIR genotypes were determined to evaluate the presence/absence 408 polymorphism of KIR genes in each individual (Fig. S5) . A prominent population of NKG2A -409 KIR + cells, representing a particularly late stage of NK cell development, was detected in 410 cultures from ILC1-like cells but were almost absent in CD56 bright -derived NK cells (mean: 411 19.8% vs. 1.6%, p-value: 0.002) ( Fig. 6c-d ). Moreover, a higher frequency of NK cells 412 expressing any of the four inhibitory KIR was observed from ILC1-like cells compared to 413 CD56 bright -derived NK cells (mean: 42.9% vs. 12.7%, p-value: 0.004) ( Fig. 6d) . A similar 414 picture emerged already after 8 days of co-cultivation (see Fig. S6 ), suggesting a rapid 415 differentiation process. ILC1-like cells created a much more diversified NK cell repertoire 416 compared to CD56 bright NK cells. All possible clonal receptor combinations were generated and 417 all KIR + clonotypes lacking NKG2A and thus representing advanced steps of NK cell 418 differentiation were more frequently found in cultures from ILC1-like cells than from CD56 bright 419 NK cells (Fig. 6e ). 420 421
Next, we were wondering, if the observed developmental potential towards the NK cell lineage 422 is similarly present in adult ILC1-like cells from peripheral blood. When cultivating flow 423 cytometrically sorted PB ILC1-like cells on OP9-DL1 stroma cells, either no or only moderate 424 NK cell expansion was detected ( Fig. S7a-b ). Nonetheless, ILC1-like cells from PB, like their 425 counterparts from CB, supported the development of mature NK cells, expressing significantly 426 more KIR2DL2/2DL3 (mean: 49.9%) compared to PB CD56 bright -dervied-NK cells (mean: 427 13.5%) ( Fig. S7c ). Furthermore, as already observed with CB, ILC1-like cells from PB were 428 able to mature into NKG2A -KIR + NK cells with higher frequency (mean: 14.7%) than 429 CD56 bright -derived NK cells (mean: 3.6%) ( Fig. S7d ). 430 431
High clonogenic potential of ILC1-like cells towards generation of mature effector NK 432 cells 433
We next analyzed the differentiation potential of neonatal ILC1-like cells on the clonal level. 434
To this end, single cells from the three major ILC1-like populations defined above 435
(CD161 + CD5 -, CD161 -CD5 + , CD161 + CD5 + ) as well as from CD56 bright NK cells were flow 436 cytometrically deposited and cloned on OP9-DL1 cells. The cloning efficiency at day 14 was 437 highest for CD56 bright NK cells (mean: 50%), followed by CD161 + CD5 + cells (mean: 35.2%), 438 CD161 + CD5 -(mean: 22.6%), and CD161 -CD5 + (mean: 15.9%) (Fig. 7a) . The NKG2A -KIR -439 subset, lacking bona fide NK cell markers was infrequent in all clonal cultures, ranging from 440 1-8% per clone thereby excluding efficient generation of any non-NK cells. Remarkably, the 441 dominant population generated from CD161 -CD5 + (mean: 92.3%) and to a lesser extent also 442 from CD161 + CD5 -ILC1-like cells (mean: 48.2%) were NKG2A -KIR + NK cells, representing 443 an advanced step of NK cell differentiation as outlined above. The population was less frequent 444 in CD161 + CD5 + clonal cultures (mean: 25.8%) and rare when starting from CD56 bright cells 445 (4.9%) ( Fig. 7b) 
465
Stimulation of NK cell clones by K562 target cells led to increased granule mobilization as 466
documented by the increased surface expression of CD107 (Fig. 7c) . Among ILC1-like subsets, 467
NK cells from CD161 + CD5 + cell showed the highest frequency of CD107 expression (mean: 468 49.2%), whereas the CD107 levels were comparable for clones generated from CD161 + CD5 -, 469 CD161 -CD5 + , or CD56 bright NK cell. Notably, elevated levels of CD107 were already observed 470 in the absence of K562 for clones derived from ILC1-like cells (Fig. 7c ), which might be due 471 to pre-activation by murine OP9-DL1 feeder cells constituting targets for the de novo generated 472 NK cells (Fig. 7d ). 473 474
Discussion 475
Here we present the identification of an ILC1-like NKP within human CB and PB that is able 476
to differentiate into mature cytotoxic NK cells. ILC1-like NKPs have a lin -CD127 + CD117 -477 CRTH2phenotype, matching innate lymphoid cells previously defined as ILC1(Bernink et al., 478 2013), but lacking expression of TBET, a common signature transcription factor of ILC1 and 479
NK cells. We demonstrate that ILC1-like cells can be broken down into two subsets, a major 480 CD5 + CD161 -/+ subset expressing the chemokine receptors CCR7, CCR4, and CCR9 and failing 481
to secrete IFN and a small CD5 -CD161 + subset not expressing any of the three chemokine 482 receptors but showing IFN secretion after specific stimulation. Despite their difference in 483 phenotype and functionality, both ILC1-like subsets possessed NKP potential. Single-cell  484 cloning experiments revealed a high NKP frequency within CB-derived ILC1-like cells and a 485 high propensity to differentiate into mature NK cells. In contrast to established CD34 + or CD34 -486 CD117 + NKPs that predominantly generate NKG2A + KIR -NK cells, differentiation of ILC1-487
like NKPs led to a high frequency of KIR + NK cells including the NKG2A -KIR + subset, 488
constituting an advanced maturation stage. The fact that neonatal ILC1-like cells are clearly 489 distinct from NK cells on the transcriptomic, epigenetic, and functional level in combination 490 with the single cell cloning experiments suggest that ILC1-like NKPs have a true progenitor 491 relationship to NK cells. 492 493
Our study provides to our knowledge the first comparison of ILC1-like and NK cells by deep 494 transcriptomic and epigenetic analysis in human blood. In the present study, ILC1-like cells 495 could be clearly distinguished from CD56 bright NK cells and the more mature CD56 dim NK cells 496 by RNAseq. The CB-derived ILC1-like cells completely lacked NK cell-specific molecules 497 such as CD94, NKG2A, and KIR on the transcriptional and surface expression level. Moreover, 498
chromatin accessibility studies demonstrated that the regulatory regions of the respective NK 499
cell receptors were open in NK cells but closed in ILC1-like cells further confirming a lack of 500 transcriptional activity for NK cell receptors in ILC1-like cells. Almost all NK cell precursors described so far are characterized by expression of CD117 517 (cKIT), the receptor for stem cell factor (SCF), including CD34 + early progenitors (stage 2) as 518 well as more differentiated CD34stages (Freud et al., 2006) . Moreover, it was previously 519
shown that CD117 is gradually downregulated during NK cell differentiation in secondary 520 lymph nodes from early to late stages of NK cell development with mature CD16 + CD56 dim NK 521 cells being the only CD117stage(Freud et al., 2016). The absence of CD117 on ILC1-like 522
NKPs represents thus an unusual feature for NK cell progenitors and demonstrates that cKIT 523 signaling is not required for triggering their inherent NK cell differentiation potential. The lack 524 of CD117 sets ILC1-like NKPs also apart from the recently described circulating Lin -525 CD7 + CD127 + CD117 + multipotent ILC progenitors (ILCp) that gave rise to all ILC subsets 526
including NK cells (Lim et al., 2017) . We thus hypothesize that circulating ILC1-like NKPs are 527 at a more advanced developmental stage than CD34 + CD117 + or CD34 -CD117 + NK cell 528 progenitors and also compared to ILCp. However, the upstream progenitor of ILC1-like NK 529 cells is currently elusive. Although it is possible that ILC1-like NK cells are developing from 530 previously described CD117 + NKPs, a linear developmental relationship between them appears 531 to be unlikely since the specific potential to generate NKG2A -KIR + NK cells could so far not 532 be detected when starting from the more immature CD117 + NKPs. 533 534
Notably, some of the most significant transcriptomic differences between ILC1-like cells and 535 NK cells pertained to the ILC1-specific expression of genes classically attributed to the T cell 536 lineage such as CD5, CD6, CD28, and also components of the CD3/TCR complex, but without the release of CD5 + ILC1-like NKP from thymus into the periphery. Of note, CD5 + ILC-like 550 cells expressing intracellular CD3 components were previously isolated from the 551 thymus (Nagasawa et al., 2017) and intracellular CD3 expression was reported previously 552 within human fetal NK cells (Phillips et al., 1992) . Further studies of thymic ILC/NK 553 progenitors will be necessary to better understand the origin of ILC1-like NKPs. 554 555
The The frequency of ILC1-like cells was particularly high in CBs of early gestational age and 580 decreased until term. Similar changes were not observed for other ILC groups that exhibited no 581 changes in relation to gestational age but significantly decreased after birth in an ageing-like 582 process. We hypothesize that the loss of ILC1-like cells is due to preferential migration into 583 tissues during the perinatal phase of development. The large majority of ILC1-like cells 584 expressed the chemokine receptor CCR7, which supports migration to SLN, an established site 585 of NK cell maturation. Further subsets co-expressed CCR4 or CCR9, supporting migration to 586 skin and the gastrointestinal tract. We thus suggest that the majority of ILC1-like NKPs travel 587 to the SLNs before and around birth to differentiate into NK cells and eventually reenter 588 circulation. The migration of ILC1-like NKPs to SLN would provide them with the necessary 589 niche signals required for further maturation. A key signal required for NK cell maturation 590
including expression of KIR is provided by NOTCH and the necessary NOTCH ligands are 591 highly expressed in SLN (Radtke et al., 2013) . Thus, the dependence of ILC1-like NKPs on 592 NOTCH signaling as observed here in OP-9 differentiation assays would support the idea of 593 migration to lymphatic tissue for successful final maturation. 594 595
In summary, the present work constitutes a thorough dissection of group 1 ILCs in neonatal 596 blood on the molecular and functional level. We demonstrate that ILC1-like cells are very 597 different from NK cells on the transcriptional, epigenetic, and functional level but instead 598 constitute a potent NKP. The lin -CD127 + CD117 -ILC1-like NKP is distinguished from 599 previously defined NKPs and ILCPs by the absence of CD117 and the presence of T cell-600 specific molecules and also by the property of generating diversified NK cell repertoires 601 characterized by KIR expression as well as the downregulation of NKG2A. ILC1-like NKPs 602
were found in CB and PB, but the latter were less potent in generating mature NK cells. The 603 study suggests high spatial and temporal dynamics within group I ILC during perinatal CD6 PE-A 10 2 10 3 10 4 10 5 10 6 10 2
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